Table 2.

Comparison of demographics, length of stay, intensive care unit admission rate, antihypertensive medications, and underlying conditions in deceased and survived COVID-19 patients

Variable	Deceased		Odds ratio (%95 CI)	P value
	Yes n = 478	No n = 2075
Gender (male)	62.5%	57.7%	1.2 (0.9, 1.5)	0.056
Age	68.9 ± 15.6	55.5 ± 17.5	1.5i (1.4, 1.6)	< 0.001
LOSa	Median = 6, IQR = 7 (3,10)	Median = 5, IQR = 5 (3,8)	1.1 (1.0, 1.2)	< 0.001
ICUb admission	56.4%	35.1%	2.4 (1.9, 2.9)	< 0.001
CVD	50.8%	33.6%	2.0 (1.6, 2.5)	< 0.001
CKDc	11.7%	8.5%	1.4 (1.0, 1.9)	0.029
CPDd	39.3%	24.0%	2.0 (1.6, 2.5)	< 0.001
DMe	28.0%	17.5%	1.8 (1.4, 2.3)	< 0.001
malignancy	3.1%	1.3%	2.4 (1.2, 4.4)	0.006
Chronic use of immunosuppressants	4.6%	0.6%	8.3 (4.0, 16.9)	< 0.001
CCBf	17.3%	8.7%	2.2 (1.6, 2.9)	< 0.001
Diuretics	4.6%	3.2%	2.8 (1.6, 4.8)	< 0.001
Beta blockers	12.1%	6.3%	2.0 (1.5, 2.8)	< 0.001
HTN	38.7%	25.5%	1.8 (1.5, 2.3)	< 0.001
ACEIsg/ARBsh	23.6%	18.6%	1.3 (1.0, 1.7)	0.013

^aLength of stay

^bIntensive care unit

^cChronic kidney disease

^dChronic pulmonary disease

^eDiabetes mellitus

^fCalcium channel blockers

^gAngiotensin converting enzyme inhibitors

^hAngiotensin receptor blockers

ⁱFor every 10 years increase